Literature DB >> 12459587

Essential role for the SMN complex in the specificity of snRNP assembly.

Livio Pellizzoni1, Jeongsik Yong, Gideon Dreyfuss.   

Abstract

The Survival of Motor Neurons (SMN) protein, the product of the spinal muscular atrophy-determining gene, is part of a large macromolecular complex (SMN complex) that functions in the assembly of spliceosomal small nuclear ribonucleoproteins (snRNPs). Using cell extracts and purified components, we demonstrated that the SMN complex is necessary and sufficient to mediate the ATP-dependent assembly of the core of seven Sm proteins on uridine-rich, small nuclear ribonucleic acids (U snRNAs). In vitro experiments revealed strict requirements for ordered binding of the Sm proteins and the U snRNAs to the SMN complex. Importantly, the SMN complex is necessary to ensure that Sm cores assemble only on correct RNA targets and prevent their otherwise promiscuous association with other RNAs. Thus, the SMN complex functions as a specificity factor essential for the efficient assembly of Sm proteins on U snRNAs and likely protects cells from illicit, and potentially deleterious, nonspecific binding of Sm proteins to RNAs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459587     DOI: 10.1126/science.1074962

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  254 in total

1.  A complex pathway for 3' processing of the yeast U3 snoRNA.

Authors:  Joanna Kufel; Christine Allmang; Loredana Verdone; Jean Beggs; David Tollervey
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

2.  In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes.

Authors:  Natalia N Singh; Elliot J Androphy; Ravindra N Singh
Journal:  RNA       Date:  2004-08       Impact factor: 4.942

3.  Failure of lower motor neuron radial outgrowth precedes retrograde degeneration in a feline model of spinal muscular atrophy.

Authors:  Erin N Wakeling; Béatrice Joussemet; Patrick Costiou; Dominique Fanuel; Philippe Moullier; Martine Barkats; John C Fyfe
Journal:  J Comp Neurol       Date:  2012-06-01       Impact factor: 3.215

4.  Post-transcriptional modification of spliceosomal RNAs is normal in SMN-deficient cells.

Authors:  Svetlana Deryusheva; Maria Choleza; Adrien Barbarossa; Joseph G Gall; Rémy Bordonné
Journal:  RNA       Date:  2011-11-28       Impact factor: 4.942

5.  Coil-in-to snRNP assembly and Cajal bodies.

Authors:  Je-Hyun Yoon; Roy Parker
Journal:  Nat Struct Mol Biol       Date:  2010-04       Impact factor: 15.369

Review 6.  The Cajal body and histone locus body.

Authors:  Zehra Nizami; Svetlana Deryusheva; Joseph G Gall
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-26       Impact factor: 10.005

7.  Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA.

Authors:  Chitra C Iyer; Vicki L McGovern; Jason D Murray; Sara E Gombash; Phillip G Zaworski; Kevin D Foust; Paul M L Janssen; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2015-08-13       Impact factor: 6.150

8.  Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery.

Authors:  Mariàngels de Planell-Saguer; David G Schroeder; Maria Celina Rodicio; Gregory A Cox; Zissimos Mourelatos
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

9.  Functional involvement of Tudor and dPRMT5 in the piRNA processing pathway in Drosophila germlines.

Authors:  Kazumichi M Nishida; Tomoko N Okada; Takeshi Kawamura; Toutai Mituyama; Yoshinori Kawamura; Sachi Inagaki; Haidong Huang; Dahua Chen; Tatsuhiko Kodama; Haruhiko Siomi; Mikiko C Siomi
Journal:  EMBO J       Date:  2009-12-16       Impact factor: 11.598

10.  Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice.

Authors:  Rocío Ruiz; Juan José Casañas; Laura Torres-Benito; Raquel Cano; Lucía Tabares
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.